To the best of our knowledge, this is the first detailed airway biopsy immunostaining study of HDAC2 expression in COPD and its potential reversibility with ICS or/and smoking cessation (albeit the latter in a cross-sectional group-comparison only at this stage). Here, HDAC2 is linked to chronic obstructive pulmonary disease.